Biblio
D
Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, P Ho J, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, et al. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. N Engl J Med. 2023.
P
Sonneveld P, Asselbergs E, Zweegman S, van der Holt B, Kersten MJosé, Vellenga E, van Marwijk-Kooy M, Broyl A, de Weerdt O, Lonergan S, et al. Phase 2 study of carfilzomib, thalidomide and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma. Blood. 2014.